Breast Cancer Research and Treatment

, Volume 24, Issue 1, pp 11–16 | Cite as

Interval cancer and survival in a randomized breast cancer screening trial in Stockholm

  • J. Frisell
  • A. von Rosen
  • M. Wiege
  • B. Nilsson
  • S. Goldman


The aim of the present study was to analyse the survival rate in a group of breast cancers detected in the intervals between screening examinations in relation to clinically detected cancers in a non-screened population. All interval and control cancers were recruited from a randomized controlled mammography screening trial in Stockholm. The overall survival up to eight years of observation was higher in 191 patients with interval cancers than in 142 control cancers (p=0.01). There were no significant differences between the two groups with regard to tumor size, stage distribution, or mean age, though the interval group did have a larger proportion of younger women. The similarity was confirmed by multiple regression analysis. The overall survival stage by stage was consistently higher in interval cancers. The survival rate in the true interval cancers was similar to that for those found in retrospect to have been detectable or traceable at the time of screening. No correlation was found between the length of the interval and the survival of patients with interval cancers. These results contradict the hypothesis that a high growth rate is associated with a poorer prognosis and that interval cancers are a more aggressive form of breast neoplasia.

Key words

breast cancer screening interval cancer overall survival 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    De Groote R, Rush BF, Milazzo J, Warden MJ, Rocho JM: Interval breast cancer: A more aggressive subset of breast neoplasias. Surgery 94: 543–547, 1983PubMedGoogle Scholar
  2. 2.
    Heuser LS, Spratt JS, Kuhns JG, Chang AFC, Polk HC Jr, Buchanan JB: The association of pathologic and mammographic characteristics of primary human breast cancers with ‘slow’ and ‘fast’ growth rates and with axillary lymph node metastases. Cancer 53: 96–98, 1984PubMedGoogle Scholar
  3. 3.
    Fournier D, Weber E, Hoeffner W, Kubbi F, Barth V: Growth rate of 147 mammary carcinomas. Cancer 45: 2198–2207, 1980PubMedGoogle Scholar
  4. 4.
    Heuser L, Spratt JS, Polk HO Jr, Buchanan J: Relation between mammary cancer growth kinetics and the intervals between screenings. Cancer 43: 857–862, 1979PubMedGoogle Scholar
  5. 5.
    von Rosen A, Erhardt K, Hellström L, Somell A, Auer G: Assessment of malignancy potential in so-called interval mammary carcinomas. Breast Cancer Res Treat 6: 221–227, 1985PubMedGoogle Scholar
  6. 6.
    Frisell J, Eklund G, Hellström L, Somell A: Analysis of interval carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 3: 219–225, 1987Google Scholar
  7. 7.
    Tabár L, Fagerberg G, Day NE, Holmberg L: What is the optimum interval between mammographic screening examinations? — An analysis on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55: 547–551, 1987PubMedGoogle Scholar
  8. 8.
    Holmberg L, Tabár L, Adami HO, Bergström R: Survival in breast cancer diagnosed between mammographic screening examinations. Lancet ii: 27–30, 1986Google Scholar
  9. 9.
    Shapiro S, Venet W, Strax P, Venet L, Roeser R: Ten to fourteen year effect of screening on breast cancer mortality. JNCI 69: 349–355, 1982PubMedGoogle Scholar
  10. 10.
    Andersson J, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfússon B: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. Br Med J 297: 943–948, 1988Google Scholar
  11. 11.
    Frisell J, Glas U, Hellström L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Design, first round results, and comparisons. Breast Cancer Res Treat 8: 45–54, 1986PubMedGoogle Scholar
  12. 12.
    Lundgren B, Jakobsson S: Single view mammography: a simple and efficient approach to breast cancer screening. Cancer 38: 1124–1129, 1976PubMedGoogle Scholar
  13. 13.
    Frisell J, Eklund G, Hellström L, Glas U, Somell A: The Stockholm breast cancer screening trial — 5 year results and stage at discovery. Breast Cancer Res Treat 13: 79–87, 1989PubMedGoogle Scholar
  14. 14.
    Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist L-E, Somell A: Randomized study of mammography screening — preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18: 49–56, 1991PubMedGoogle Scholar
  15. 15.
    Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: Analysis and examples. Br J Cancer 35: 1–39, 1977PubMedGoogle Scholar
  16. 16.
    Cox DR: Regression models and life-tables (with discussion). J Royal Statist Soc B 34: 187–220, 1972Google Scholar
  17. 17.
    Tabár L, Fagerberg G, Gad A, Baldetorp L, Holmberg LH, Gröntoft D, Ljungqvist U, Lundström B, Månsson IC, Eklund G, Pettersson F, Day NE: Reduction in mortality from breast cancer after mass screening with mammography. Lancet i: 829–832, 1985Google Scholar

Copyright information

© Kluwer Academic Publishers 1992

Authors and Affiliations

  • J. Frisell
    • 1
  • A. von Rosen
    • 1
  • M. Wiege
    • 2
  • B. Nilsson
    • 3
  • S. Goldman
    • 1
  1. 1.From the Department of SurgeryKarolinska HospitalStockholmSweden
  2. 2.the Department of Radiology, Södersjukhuset, StockholmKarolinska HospitalStockholmSweden
  3. 3.the Department of Cancer EpidemiologyKarolinska HospitalStockholmSweden

Personalised recommendations